GBP2 is a prognostic biomarker and associated with immunotherapeutic responses in gastric cancer

GBP2 is a prognostic biomarker and associated with immunotherapeutic responses in gastric cancer

Abstract Background The interferon-induced protein known as guanylate-binding protein 2 (GBP2) has been linked to multiple different cancer types as an oncogenic gene. Although the role of GBP2 in cancer has been preliminarily explored, it is unclear how this protein interacts with tumor immunity in...

Full description

Bibliographic Details
Main Authors: Yunfei Wang, Jiadong Pan, Fangmei An, Ke Chen, Jiawei Chen, He Nie, Yanping Zhu, Zhengtao Qian, Qiang Zhan
Format: Article
Language:English
Published: BMC 2023-10-01
Series:BMC Cancer
Subjects:
GBP2
Gastric cancer
Immunotherapy
Biomarker
Online Access:https://doi.org/10.1186/s12885-023-11308-0

Similar Items

Similar Items